Chemours Co: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Aug 9, 2016 and accepted by EDGAR at Aug 9, 2016, 15:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2016-04-01 to 2016-06-30 | $1.12bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2016-01-01 to 2016-06-30 | $2.21bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2016-04-01 to 2016-06-30 | $267.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2016-01-01 to 2016-06-30 | $468.0m | us-gaap:GrossProfit |
| Research and development | 3 months2016-04-01 to 2016-06-30 | $17.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2016-01-01 to 2016-06-30 | $40.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-04-01 to 2016-06-30 | $174.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2016-01-01 to 2016-06-30 | $307.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2016-04-01 to 2016-06-30 | $50.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-06-30 | $106.0m | us-gaap:InterestExpense |
| Income tax | 3 months2016-04-01 to 2016-06-30 | −$23.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-06-30 | −$5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-01 to 2016-06-30 | −$18.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | $33.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | $0.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | $0.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-01 to 2016-06-30 | 181,477,672 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-06-30 | 182,047,829 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-01-01 to 2016-06-30 | $126.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2016-01-01 to 2016-06-30 | $168.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2016-01-01 to 2016-06-30 | $11.0m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2016-06-30 | $383.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $2.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $6.22bn | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $1.44bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $6.05bn | us-gaap:Liabilities |
| Long-term debt | At period end2016-06-30 | $3.82bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-06-30 | $36.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2016-06-30 | $165.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001627223-16-000139. Last ingested by Listed: Nov 5, 2026, 19:57 ET. Listed shows no prices and gives no investment advice.